 |
| Dr. Nicola Mason with Sheba. Photo Penn Vet |
Immunotherapy has already had promising results in prevention of metastatic disease and prolonging overall survival of dogs that have undergone amputation and chemotherapy.
The purpose of this study is to evaluate whether vaccination with a tumor-targeting cancer vaccine, combined with radiation therapy, can decrease bone cancer pain and prolong overall survival.
The treatment of the dog first enrolled in this trial has shown promising results.
Dog owners interested in enrolling a dog in this study can contact Dr. Mason at nmason@vet.upenn.edu or
215-898-3996. Eligibility and trial details can be found here. Source article:
Penn Vet Recruiting Dogs for Bone Cancer Vaccine Clinical Trial